
CEO Sarah London said the company will lose clients during the redetermination process. It also expect its Medicare Advantage business to grow in 2024.
Your trusted source of news.
CEO Sarah London said the company will lose clients during the redetermination process. It also expect its Medicare Advantage business to grow in 2024.